Retinitis clinical trials
The registry lists 250 studies for Retinitis across more than 10 countries. 28 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-07-01.
Status
- Completed
- 162
- Status unknown
- 26
- Recruiting
- 19
- Terminated
- 16
- Active, not recruiting
- 11
- Withdrawn
- 7
Phase
- Phase 2
- 63
- Phase 1
- 52
- Phase 3
- 19
- Early Phase 1
- 6
- Phase 4
- 3
Where
- United States
- 126
- United Kingdom
- 22
- Germany
- 21
- France
- 18
- Canada
- 14
- China
- 12
Who runs them
National Institute of Allergy and Infectious Diseases (NIAID) (21) · National Eye Institute (NEI) (13) · Hoffmann-La Roche (8) · Second Sight Medical Products (6) · Johns Hopkins Bloomberg School of Public Health (6) · Johns Hopkins University (6) · Ankara Universitesi Teknokent (5) · Nanoscope Therapeutics Inc. (5)
Studies
Recruiting first, then most recently updated. Showing 50 of 250 — search for more.
- Evaluation of Safety and Efficacy of Autologous LB-DTK-CMV in Patients With Antiviral-Resistant and Refractory Cytomegalovirus Retinitis.RecruitingNCT07679412Not applicable1 country
- Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at SanfordRecruitingNCT017931682 countries
- InsightRP2 RegistryRecruitingNCT069824171 country
- Safety and Efficacy of Stem Cell Small Extracellular Vesicles in Patients With Retinitis PigmentosaRecruitingNCT06242379Phase 1/21 country
- Study of Subretinally Injected AAVB-081 in Patients With Usher Syndrome Type IB (USH1B) Retinitis PigmentosaRecruitingNCT06591793Phase 1/22 countries
- An Open-label, Dose-ascending Study of IGT001 for Retinitis PigmentosaRecruitingNCT06936787Phase 11 country
- Evaluating a New Peptide Therapy for Retinal Diseases: AMD, Diabetic Retinopathy, and DystrophiesRecruitingNCT06787482Phase 1/21 country
- Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for NAIONRecruitingNCT05147701Phase 12 countries
- Functional Assessments in Vision ImpairmentNot yet recruitingNCT069081611 country
- Safety and Tolerability of Intravitreal Administration of VG901 in Patients With Retinitis Pigmentosa Due to Mutations in the CNGA1 GeneRecruitingNCT06291935Phase 11 country
- A Long-Term Follow-Up Study in Subjects Who Received vMCO-I Administered Via Intravitreal InjectionEnrolling by invitationNCT059211621 country
- Retinal Investigation Using Optos OCT DeviceNot yet recruitingNCT06846151Not applicable
- Observational Study to Assess Endpoint Operational Feasibility & Measurement Properties in Patients with Retinal DegenerationRecruitingNCT063752391 country
- A Study Comparing Two Doses of AGTC-501 in Male Participants With X-linked Retinitis Pigmentosa Caused by RPGR Mutations (DAWN)Enrolling by invitationNCT06275620Phase 21 country
- Longitudinal Study of a Bionic EyeEnrolling by invitationNCT051580491 country
- A New Diagnostic Paradigm for Retinitis Pigmentosa Secondary to USH2A Pathogenic VariantsNot yet recruitingNCT06545253
- Gene Therapy for RPGR Gene Mutation-associated X-linked Retinitis PigmentosaRecruitingNCT06492850Phase 1/21 country
- Evaluation of Objective Perimetry Using Chromatic Multifocal PupillometerRecruitingNCT020143891 country
- Biomarkers in Retinitis PigmentosaRecruitingNCT063066901 country
- Coloured-light in Retinitis Pigmentosa.Not yet recruitingNCT06224114Not applicable1 country
- Safety and Tolerability Study of Gene Editing Drug ZVS203e in Participants With Retinitis PigmentosaRecruitingNCT05805007Early Phase 11 country
- Evaluation of New Head-mounted Visual Aids Among Patients With Low VisionNot yet recruitingNCT06076720Not applicable1 country
- Clinical Study of High Concentration Ganciclovir Eye Drops in the Treatment of Cytomegalovirus RetinitisRecruitingNCT05911503Early Phase 11 country
- Gene Therapy for Subjects With RPGR Mutation-associated X-linked Retinitis PigmentosaRecruitingNCT05874310Early Phase 11 country
- Clinical Implication of Retinitis Pigmentosa Molecular Diagnostic Using High Throughput Sequencing.RecruitingNCT028605201 country
- Structural and Functional Characterization of Rare Ocular DiseasesRecruitingNCT052580321 country
- Phenotype Correlates Genotype of Inherited Retina Dystrophies, Retinitis Pigmentosa, Con>Rod Dystrophies.RecruitingNCT039907271 country
- Clinical Trials of Continuous Oxygen Therapy Combined With Blue Light Deprivation in the Treatment of Retinitis PigmentosaNot yet recruitingNCT02465749Early Phase 11 country
- Intravitreal Quantum Dots (QD) for Advanced Retinitis Pigmentosa (RP) (QUANTUM)WithdrawnNCT05841862Not applicable
- Prospective Natural History Study of Retinitis PigmentosaActive, not recruitingNCT04285398Not applicable2 countries
- Clinical Characterization on PDE6A-related Retinitis Pigmentosa in Preparation to a Gene Therapy TrialCompletedNCT027599521 country
- A Study of Encapsulated Cell Technology (ECT) Implant for Participants With Early Stage Retinitis PigmentosaCompletedNCT00447980Phase 21 country
- An Observational Study of Japanese Participants With X-linked Retinitis PigmentosaCompletedNCT048689161 country
- Mechanisms of Inherited Retinal Dystrophies Using Whole Genome Sequencing and in Vitro and in Vivo ModelsCompletedNCT057935151 country
- Non-Interventional Long Term Follow-up Study of Participants Previously Enrolled in the RESTORE StudyActive, not recruitingNCT061625852 countries
- Natural History Study of Retinitis Pigmentosa Type 11Active, not recruitingNCT048056581 country
- 4D-125 in Patients With X-Linked Retinitis Pigmentosa (XLRP)Active, not recruitingNCT04517149Phase 1/21 country
- Environmental Localization Mapping and Guidance for Visual Prosthesis UsersCompletedNCT04359108Not applicable1 country
- Advancing Understanding of Transportation OptionsCompletedNCT04141891Not applicable1 country
- Gene Therapy for X-linked Retinitis Pigmentosa (XLRP) - Retinitis Pigmentosa GTPase Regulator (RPGR)CompletedNCT03252847Phase 1/22 countries
- The Perceptual Experience of Argus II UsersCompletedNCT05285618Not applicable1 country
- A Natural History Study to Evaluate Functional and Anatomical Progression in Retinitis PigmentosaTerminatedNCT045589831 country
- Visual Activity Evoked by Infrared in Humans After Dark AdaptationCompletedNCT02909985Not applicable1 country
- Oral Hydroxychloroquine (HCQ) for Retinitis Pigmentosa Caused by P23H- Rhodopsin (RHO)TerminatedNCT04120883Phase 1/21 country
- Development of Visual Function Evaluation Method (2)CompletedNCT036262071 country
- Development of Visual Function Evaluation MethodCompletedNCT032810051 country
- Object Finder for a Retinal ProsthesisCompletedNCT04319809Not applicable1 country
- Dose Escalation Study to Evaluate the Safety/Tolerability and Efficacy of EA-2353 in Subjects With Retinitis PigmentosaTerminatedNCT05392751Phase 1/21 country
- Phase 1 Study of Intravitreal Autologous CD34+ Stem Cell Therapy for Retinitis PigmentosaCompletedNCT04925687Phase 11 country
- A Study of Encapsulated Cell Technology (ECT) Implant for Patients With Late Stage Retinitis PigmentosaCompletedNCT00447993Phase 21 country